Redmile Group, LLC Atreca, Inc. Transaction History

Redmile Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.78 - $1.68 $278,969 - $600,857	-357,653 Reduced 44.69%	442,653 $354,000
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $1.06 Million - $2.33 Million	-369,700 Reduced 31.6%	800,306 $2.43 Million
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $6.34 Million - $11.7 Million	-1,290,262 Reduced 52.44%	1,170,006 $7.29 Million
Q2 2021 Aug 16, 2021	SELL	$7.82 - $13.8 $236,946 - $418,140	-30,300 Reduced 1.22%	2,460,268 $21 Million
Q1 2021 May 17, 2021	BUY	$13.0 - $19.34 $188,500 - $280,430	14,500 Added 0.59%	2,490,568 $38.2 Million
Q4 2020 Feb 16, 2021	SELL	$13.03 - $17.09 $939,463 - $1.23 Million	-72,100 Reduced 2.83%	2,476,068 $40 Million
Q3 2020 Nov 16, 2020	BUY	$12.67 - $23.19 $19.7 Million - $36.1 Million	1,556,100 Added 156.85%	2,548,168 $35.6 Million
Q2 2020 Aug 14, 2020	SELL	$12.52 - $23.45 $1.71 Million - $3.21 Million	-136,738 Reduced 12.11%	992,068 $21.1 Million
Q1 2020 May 15, 2020	SELL	$11.4 - $27.28 $91,200 - $218,240	-8,000 Reduced 0.7%	1,128,806 $18.7 Million
Q4 2019 Feb 14, 2020	SELL	$9.68 - $18.67 $22,264 - $42,941	-2,300 Reduced 0.2%	1,136,806 $17.6 Million
Q3 2019 Nov 14, 2019	SELL	$10.42 - $22.04 $12,504 - $26,448	-1,200 Reduced 0.11%	1,139,106 $13.9 Million
Q2 2019 Aug 14, 2019	BUY	$17.07 - $18.84 $19.5 Million - $21.5 Million	1,140,306 New	1,140,306 $21.5 Million

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.